Fish Health

​​​​​​​P.salmonis

Farmed salmon can be affected by Piscirickettsia salmonis (P. salmonis), a naturally occurring bacterial disease present in the marine environment. 

P.salmonis does not present a human health, or food safety risk.  

The bacteria does not pose a risk to freshwater fish and it is not known to pose a threat to other marine (saltwater) species.

 Piscirickettsia salmonis Information Sheet (PDF 131Kb)​

Treatment

Aquaculture medicines are treatments used in aquaculture, to manage and treat disease outbreaks and parasites in farmed fish and are an important tool for protecting fish health and welfare. 

Without appropriate treatment options, disease outbreaks can result in increased fish mortality, animal welfare impacts.

Medicines may be used through a range of established pathways, including medicines approved through national regulatory processes and medicines prescribed by veterinarians under veterinary practice arrangements. These pathways recognise the importance of maintaining animal health and welfare while ensuring appropriate regulatory oversight.

Antibiotics may be used for P.Salmonis. Farmed salmon producers must advise the Environment Protection Authority (EPA) Director and the NRE Tas Chief Veterinary Officer prior to administration of any antibiotic. They must also comply with any requirements for testing residues and reporting. 

Interactive map​​

This interactive map opens at a general view. Zoom in and move around the map to navigate to your area of interest and to view the available information.​ 

The yellow outline is the Approved Therapeutant Treatment Areas and Blue is the Aquaculture Marine Leases. 

​​​​

Regulatory oversight​

Before administering antibiotics, salmon producers must notify:

  • The Environment Protection Authority (EPA), and

  • Biosecurity Tasmania, part of the Department of Natural Resources and Environment Tasmania (NRE Tas).

These agencies are responsible for ensuring the safe and responsible use of antibiotics in marine farming:

  • EPA oversees environmental monitoring to ensure antibiotic use does not cause harm to marine ecosystems.

  • NRE Tas administers the Biosecurity Program: Tasmanian Salmonid Industry, and enforces the Tasmanian Primary Produce Safety Act 2011 and the Primary Produce Safety (Seafood) Regulations 2023, which govern food safety standards in seafood production.

​Public Health​​​​​

The Department of Health provides public health advice for antibiotic treatment.

Advice from Public Health about Oxytetracycline and Recreational Fishing in The D'Entrecasteaux Channel and Adjacent Waters​ was published on ​6 October 2026. ​

Additional information can be found by visiting the Department of Health website​.

Therapeutant management

The detection and presence of veterinary medicine residues in aquatic food products can affect market access and trade certification, even when food safety and environmental risks are low.

The Aquaculture Therapeutant - Wild Fisheries Market Access Management Plan provides a consistent, risk-based framework that protects market access and trade integrity, while supporting transparent decision-making and providing confidence to trading partners:

 Aquaculture Therapeutant - Wild Fisheries Market Access Management Plan (PDF 10Mb)

ShellMAP is responsible for maintaining the safety and market access of Tasmanian shellfish. The Aquaculture Therapeutant - Wild Fisheries Market Access Management Plan primarily focuses on managing risks to wild fisheries species. Farmed shellfish market access requirements must also be considered:

 Shellmap fact sheet _Shellfish Aquaculture and Therapeutant Use (PDF 134Kb)

Visit our Regulator Statement web page​ for more information.